Chapter 7: A Pattern Emerges

That evening, a quiet Italian restaurant in Boston provided the backdrop for Dr. Sharma’s delicate dance with Dr. Ben Carter. The clinking of glasses and soft murmur of conversation offered a cloak of anonymity, a stark contrast to the watchful eyes of St. Jude’s. Dr. Sharma chose her questions with surgical precision, aiming to extract information without triggering Dr. Carter’s obvious discomfort or fear of violating his NDA.

They began with general discussions about the challenges of managing large foundations, the complexities of grant allocations, and the delicate balance between donor intent and scientific independence. Dr. Carter, initially guarded, began to relax slightly, finding common ground in their shared commitment to ethical practices.

“It’s a fine line, isn’t it?” Dr. Carter mused, swirling the wine in his glass. “Donors want impact, but sometimes they want to control the narrative too much. To the point where… well, the truth becomes inconvenient.”

“Inconvenient how?” Dr. Sharma prompted gently, her voice calm and encouraging. She wasn’t asking about Silas Croft directly, but about the general principle.

Dr. Carter hesitated, picking at a breadstick. “I’ve seen situations where a foundation head believes their ‘vision’ for a project is paramount, even if the researchers on the ground suggest a different, more scientifically sound path. And if those researchers push back… things can get messy.”

He took a deep breath, clearly steeling himself. “There was an instance, about five years ago, at a small biomedical research lab in Connecticut. They received a significant grant from the Croft Foundation, specifically for early-stage gene therapy research.”

Dr. Sharma felt a jolt. Five years ago. Connecticut. It aligned eerily with the news clipping I had found, the lawsuit against the Croft Foundation. This was the precise period and location of Silas’s modus operandi.

“The lead researcher, a brilliant but very outspoken woman, Dr. Eleanor Vance, started questioning some of the expenditures,” Dr. Carter continued, his voice softer now, almost regretful. “Specifically, she noticed funds being routed through a holding company for ‘administrative overhead’ that seemed unusually high.”

The detail of the “holding company” for “administrative overhead” was a specific, personal cruelty beat. It highlighted a manipulative financial tactic designed to obscure diversions, not just an abstract financial wrong. It was a classic sign of someone trying to hide something.

“And what happened then?” Dr. Sharma asked, leaning forward slightly.

Dr. Carter’s jaw tightened. “Silas Croft was furious. He considered it an attack on his generosity, his integrity. He pulled the funding, abruptly. Citing ‘performance issues’ and ‘lack of alignment with the foundation’s core mission’.”

“But that wasn’t the real reason, was it?” Dr. Sharma ventured, knowing the answer.

He shook his head, a grim expression on his face. “No. Dr. Vance’s research was actually showing promising results. But she had looked too closely at the books. Silas… he doesn’t tolerate that.”

He lowered his voice further. “Then, he started a quiet campaign. Rumors about Dr. Vance’s ‘difficult personality,’ her ‘inability to manage large projects,’ even subtle suggestions of ‘mismanagement of her own team.’ Anything to discredit her professionally.”

This specific personal cruelty beat of spreading rumors and attacking reputation, not just finances, was chilling. It showed Silas Croft’s comprehensive approach to silencing dissent, aiming to destroy careers and reputations. It was the “blacklisting” hinted at in the escalation rounds.

“So, he effectively sabotaged her career,” Dr. Sharma concluded, the anger evident in her voice.

“Completely,” Dr. Carter affirmed, a look of profound regret on his face. “The lab lost its funding, couldn’t secure new grants, and eventually folded. Dr. Vance struggled to find a new position in research. It was a tragedy.”

He looked at Dr. Sharma, his eyes filled with a raw honesty. “I saw it all happen. I was privy to some of the financial decisions that led to that ‘administrative overhead.’ But I was under a very strict NDA, and I was… I was afraid of Silas Croft’s reach.”

The admission was a powerful secret, confirming not just Silas’s pattern, but also Ben’s direct knowledge and his own past compromise, mirroring Dr. Sharma’s earlier confession to me. This shared experience of powerful figures using financial leverage to silence legitimate concerns created an immediate bond between them.

“I understand,” Dr. Sharma said, her voice filled with empathy. She knew exactly how he felt.

“I left the foundation not long after that incident,” Dr. Carter continued. “I couldn’t stomach working for him anymore, knowing what he was capable of. But the NDA… it’s comprehensive. I can’t directly give you anything. I can’t break it.”

He looked genuinely distressed, the internal conflict clear on his face. He wanted to help, but he was bound by legal constraints and a very real fear of the consequences. This was the pattern of Silas’s modus operandi, now made explicit with a specific past incident.

“I appreciate your honesty, Dr. Carter,” Dr. Sharma replied, her mind already racing. “Knowing this pattern is invaluable. It tells me we’re on the right track.”

“Just be careful,” he warned, his voice grave. “Silas Croft is not just financially powerful. He’s vindictive. And he has a way of making sure anyone who crosses him pays a very heavy price.”

He looked at her, his expression a mixture of caution and a desperate plea. “If you do pursue this, Dr. Sharma, you have to be absolutely watertight. He will come after you with everything he has.”

The conversation wound down after that, filled with polite generalities. But the true import of their discussion was clear. Dr. Sharma now had confirmation of Silas Croft’s history, a specific incident mirroring my own, and a direct link to someone who had witnessed it firsthand. Dr. Carter’s detailed, though reluctant, revelation of the past incident made the pattern undeniable, giving Dr. Sharma a solid lead to follow, despite his inability to provide concrete details due to the NDA. This secret, now revealed, would be the foundation of our counter-attack.